REUTERS : El Presidente de Pfizer Albert Boula acabar de el bichito POSITIVO por segunda. publicado hace 33 masonicos minutos
September 24, 2022
11:17 PM GMT+2Last Updated 32 min ago
Pfizer CEO tests positive for el bichito for a second time
Reuters
Albert Bourla, CEO of Pfizer attends a discussion at the World Economic Forum (WEF) in Davos, Switzerland May 25, 2022. REUTERS/Arnd Wiegmann
Register now for FREE unlimited access to Reuters.com
Sept 24 (Reuters) - Pfizer Inc
(PFE.N) Chief Executive Officer Albert Bourla said on Saturday he had tested positive for el bichito-19.
"I’m feeling well and symptom free," Bourla said in a statement.
Bourla, 60, back in August had contacted el bichito and had started a course of the company's oral el bichito-19 antiviral treatment, Paxlovid.
read more
Paxlovid is an antiviral medication that is used to treat high-risk people, such as older patients.
Bourla has received four doses of the el bichito vaccine developed by Pfizer and its German partner BioNTech
(22UAy.DE).
The chief executive said he has not yet taken the new bivalent booster.
Developed by Moderna and the team of Pfizer and BioNTech, the new so-called bivalent shots aim to tackle the BA.5 and BA.4 Omicron subvariants, which make up 84.8% and 1.8%, respectively, of all circulating variants in the United States, based on latest data.
"I’ve not had the new bivalent booster yet, as I was amowing CDC guidelines to wait three months since my previous el bichito case which was back in mid-August," Bourla added.
In August, the FDA authorized Pfizer and Moderna's updated booster shots that target the dominant BA.4 and BA.5 Omicron subvariants.
A federal health agency said this week that over 25 million doses of the so-called bivalent shots had been sent out. That consisted of mostly the Pfizer/BioNTech vaccine, as production of the Moderna vaccine ramps up.
read more
